MNST

Monster Beverage
D

MNST

Arincen82/100B

Monster Beverage executives and insider trading

Guy Carling sold 57,438 shares for 4.47M USD in 2 sales over the last twelve months, the last on 10 June 2026, and bought none on the open market.

Over the last twelve months Monster Beverage's insiders sold 453,681 shares for 35.60M USD in 10 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
10
Shares sold
453,681
Value sold
35.60M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
0
0
6 months
15.46M USD
0
1 year
35.60M USD
0
2 years
52.98M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Guy Carling CEOChief Executive Officer for EMEA & OSP4957,4384.47M USD—10 Jun 202621,863
Rodney C Sacks Director—206,54315.20M USD—12 Dec 2025217,307
Emelie C. Tirre Chief Strategy Officer56128,70010.68M USD—14 May 202674,011
Mark J Hall Director—54,0004.63M USD—14 May 2026353,246
Thomas J. Kelly Chief Financial Officer727,000614.67K USD—13 May 202662,553

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
10 Jun 2026Guy CarlingSale19,00090.901.73M USD21,863Form 4
14 May 2026Mark J HallSale54,00085.814.63M USD299,246Form 4
14 May 2026Emelie C. TirreSale10,00085.74857.40K USD71,763Form 4
13 May 2026Thomas J. KellySale7,00087.81614.67K USD62,553Form 4
13 May 2026Emelie C. TirreSale88,70085.967.62M USD81,763Form 4
12 Dec 2025Emelie C. TirreSale30,00073.312.20M USD63,939Form 4
12 Dec 2025Rodney C SacksSale16,99773.581.25M USD360,948Form 4
12 Dec 2025Rodney C SacksSale137,20473.5810.10M USD286,228Form 4
12 Dec 2025Rodney C SacksSale52,34273.583.85M USD—Form 4
13 Nov 2025Guy CarlingSale38,43871.332.74M USD21,993Form 4
13 Aug 2025Mark VidergauzSale10,00063.73637.30K USD51,191Form 4
29 May 2025Thomas J. KellySale27,00063.401.71M USD69,273Form 4
16 May 2025Emelie C. TirreSale8,79662.46549.40K USD89,501Form 4
14 May 2025Mark VidergauzSale3,50060.62212.17K USD57,599Form 4
14 Mar 2025Thomas J. KellySale10,00055.27552.70K USD72,273Form 4

Common questions about Monster Beverage's executives and insiders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.